DarioHealth (DRIO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist

0.893
-0.028-2.99%

Close Nov 5 16:00 ET

27.96MMarket Cap-762P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Dario Expands Pharma Collaborations With Global Pharma To Further Direct-To-Consumer Efforts Using Dario's Refined Engagement And Navigation Technologies.
BenzingaNov 4 08:31 ET
Express News | Dario Expands Pharma Collaborations With Global Pharma To Further Direct-To-Consumer Efforts Using Dario's Refined Engagement And Navigation Technologies
BenzingaNov 4 08:31 ET
Dario Expands Pharma Collaborations With Global Pharma Leader to Enhance User Engagement
PRNewswireNov 4 08:30 ET
Earnings Preview: DarioHealth to Report Financial Results Pre-market on November 07
Moomoo NewsNov 1 21:00 ET
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
PR NewswireOct 30 08:30 ET
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
BusinesswireOct 28 16:44 ET

Comments

Jaguar8

Sep 10 07:32

NEWS

$DarioHealth (DRIO.US)$
Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
Members with depression showed highe...

NRAO

Sep 3 10:37

$DarioHealth (DRIO.US)$ holding this for almost 4 months

Trytosaveabit

Jul 16 07:32

Update

$DarioHealth (DRIO.US)$ Reuters· just
DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3

Jaguar8

Jun 25 07:30

NEWS

$DarioHealth (DRIO.US)$
Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...

Trytosaveabit

May 15 05:38

$DarioHealth (DRIO.US)$ Enveric Biosciences Q1 Net Income USD -2.46 Million
DarioHealth Q1 Net Loss $(7.2)M Compared To $(12.8)M YoY
DarioHealth Corp Qtrly Shr Loss $0.20
DarioHealth Q1 Revenue USD 1.791 Million

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

DRIO DarioHealth

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target